Agresta; Samuel V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Agresta; Samuel V..The latest application filed is for "methods of using pyruvate kinase activators".
- Agresta; Samuel V. - Lexington MA
| Patent | Date |
|---|---|
| Combination therapy for treating malignancies Grant 11,419,859 - Agresta August 23, 2 | 2022-08-23 |
| Methods Of Using Pyruvate Kinase Activators App 20220211697 - Agresta; Samuel V. ; et al. | 2022-07-07 |
| Methods of using pyruvate kinase activators Grant 11,234,976 - Agresta , et al. February 1, 2 | 2022-02-01 |
| Combination Therapy For Treating Malignancies App 20210386749 - Agresta; Samuel V. | 2021-12-16 |
| Therapy For Treating Malignancies App 20210205281 - Agresta; Samuel V. | 2021-07-08 |
| Therapeutically Active Compounds And Their Methods Of Use App 20210155603 - Agresta; Samuel V. ; et al. | 2021-05-27 |
| Therapy for treating malignancies Grant 10,980,788 - Agresta April 20, 2 | 2021-04-20 |
| Combination Therapy For Treating Malignancies App 20210100805 - Chopra; Vivek Saroj Kumar ; et al. | 2021-04-08 |
| Combination therapy for treating malignancies Grant 10,905,692 - Agresta February 2, 2 | 2021-02-02 |
| Combination Therapy For Treating Malignancies App 20200405737 - Agresta; Samuel V. ; et al. | 2020-12-31 |
| Therapeutically active compounds and their methods of use Grant 10,730,854 - Agresta , et al. | 2020-08-04 |
| Combination therapy for treating malignancies Grant 10,695,352 - Chopra , et al. | 2020-06-30 |
| Combination therapy for treating malignancies Grant 10,653,710 - Agresta , et al. | 2020-05-19 |
| Methods Of Using Pyruvate Kinase Activators App 20200030322 - Agresta; Samuel V. ; et al. | 2020-01-30 |
| Therapy For Treating Malignancies App 20190374522 - Agresta; Samuel V. | 2019-12-12 |
| Therapeutically Active Compounds And Their Methods Of Use App 20180370951 - Agresta; Samuel V. ; et al. | 2018-12-27 |
| Combination Therapy For Treating Malignancies App 20180311249 - Agresta; Samuel V. | 2018-11-01 |
| Combination Therapy For Treating Malignancies App 20180303840 - Chopra; Vivek Saroj Kumar ; et al. | 2018-10-25 |
| Combination Therapy For Treating Malignancies App 20180303808 - Agresta; Samuel V. | 2018-10-25 |
| Therapeutically active compounds and their methods of use Grant 10,105,369 - Agresta October 23, 2 | 2018-10-23 |
| Combination Therapy For Treating Malignancies App 20180296583 - Agresta; Samuel V. ; et al. | 2018-10-18 |
| Therapeutically active compounds and their methods of use Grant 10,093,654 - Agresta , et al. October 9, 2 | 2018-10-09 |
| Therapeutically Active Compounds And Their Methods Of Use App 20180125850 - Agresta; Samuel V. | 2018-05-10 |
| Therapeutically active compounds and their methods of use Grant 9,889,137 - Agresta February 13, 2 | 2018-02-13 |
| Therapeutically Active Compounds And Their Methods Of Use App 20170305885 - Agresta; Samuel V. ; et al. | 2017-10-26 |
| Therapeutically Active Compounds And Their Methods Of Use App 20170266193 - Agresta; Samuel V. | 2017-09-21 |
| Therapeutically active compounds and their methods of use Grant 9,738,625 - Agresta , et al. August 22, 2 | 2017-08-22 |
| Therapeutically active compounds and their methods of use Grant 9,694,013 - Agresta July 4, 2 | 2017-07-04 |
| Therapeutically Active Compounds And Their Methods Of Use App 20160194305 - AGRESTA; Samuel V. ; et al. | 2016-07-07 |
| Therapeutically Active Compounds And Their Methods Of Use App 20160089374 - AGRESTA; Samuel V. | 2016-03-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 